BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2009
View Archived Issues
Novel anticancer compounds in early development at Pharminox
Read More
Dainippon Sumitomo Pharma discovers new renin inhibitors for the treatment of hypertension
Read More
HDAC inhibitors claimed by CrystaX Pharmaceuticals for cancer treatment
Read More
Debiopharm and Mercury sign exclusive license agreement for Debio-0930
Read More
Novartis initiates shipments of seasonal flu vaccine Fluvirin to U. S. for 2009-2010 season
Read More
FDA extends PDUFA date for Pennsaid NDA to November 2009
Read More
FDA accepts for review Kamada's BLA for IV-AAT for alpha-1 antitrypsin deficiency
Read More
FDA approves Firmagon name for Ferring's prostate cancer treatment degarelix
Read More
Progenics and Wyeth submit applications to FDA and EMEA for Relistor prefilled syringes
Read More
Phase Ib data show antitumor activity of low-dose NGR-hTNF in advanced solid tumors
Read More
Carisbamate reduces alcohol preference and intake in alcohol-preferring rats
Read More
No difference in viral dynamics in ABC/3TC and TDF/FTC in ART-naive HIV-1 subjects
Read More
Mirabegron does not affect PK, PD and safety profiles of metformin in healthy adults
Read More
EMEA withdraws marketing authorization for Posaconazole SP
Read More
Cilostazol confers neuroprotection in rat model of cerebral hypoperfusion
Read More
TRPV1 vanilloid receptor antagonists disclosed by Glenmark Pharmaceuticals
Read More
Vereniging VU-Windesheim presents H4 receptor ligands for the treatment of inflammatory disorders
Read More
PPAR agonists synthesized for the treatment or prevention of diabetes at sanofi-aventis
Read More
Labopharm files NDS with Health Canada for formulation of antidepressant trazodone
Read More
NicOx to reacquire development and commercialization rights to PF-03187207 from Pfizer
Read More
Bellicum initiates dosing in phase I/II clinical trial of BP-GMAX-CD1 in prostate cancer
Read More
EMEA grants orphan drug designation to Aradigm's inhaled liposomal ciprofloxacin in CF
Read More
European Commission grants marketing authorization to Genzyme's Mozobil
Read More
ProStrakan submits Abstral NDA to FDA for breakthrough cancer pain
Read More
Galapagos reports results from phase I trial of GLPG-0259 in rheumatoid arthritis
Read More
FDA extends PDUFA date from August to November 2009 for NeurogesX's Qutenza NDA
Read More